Based on the previous experimental results, we wanted to know whether CRABP2 could affect the metabolism of ovarian cancer cells by regulating the expression of HIF1α, ultimately affecting the sensitivity of tumor cells to chemotherapy drugs. This evidence concerns the gene CRABP2 and ovarian carcinoma.